Table 2.

Initial vs. final assessment among women with a recent screening examination in the Breast Cancer Surveillance Consortium, 2005–2017.

	Final Assessment
Initial Assessment	Negative (BI-RADS 1,2)	Short-interval follow-up (BI-RADS 3)	Biopsy recommendation (BI-RADS 4,5)	Total
All screens
Negative (BI-RADS 1,2)	2,295,935 (91.4%)	NA	NA	2,295,935 (91.4%)
Positive (BI-RADS 0,3,4,5)	140,438 (5.6%)	41,889 (1.7%)	34,315 (1.4%)	216,642 (8.6%)
Total	2,436,373 (97.0%)	41889 (1.7%)	34,315 (1.4%)	2,512,577 (100.0%)
Screens followed by a cancer diagnosis
Negative (BI-RADS 1,2)	1,736 (14.3%)	NA	NA	1,736 (14.3%)
Positive (BI-RADS 0,3,4,5)	195 (1.6%)	551 (4.5%)	9,649 (79.5%)	10,395 (85.7%)
Total	1,931 (15.9%)	551 (4.5%)	9,649 (79.5%)	12,131 (100.0%)